Get the app!
Back to Trades

Posard Matthew L.

DirectorCIK 0001543792

Largest Purchase

No open-market purchases in the recent filings.

Profile

Filings
4
Buy transactions
0
Sell transactions
8
Companies
2
Active
2026

Across 4 filings between 2026, Posard Matthew L., Director, has disclosed $3.1M in transactions — spread across 2 companies. Their disclosed trades are heavily weighted toward selling — $0 in buys and $2.6M in sells. Data is sourced from official SEC Form 3, 4, and 5 filings.

Trading History

4 loaded
Oct 2HALO
HALOZYME THERAPEUTICS, INC.
Posard Matthew L.DirectorSell$567.7K
Sep 17HALO
HALOZYME THERAPEUTICS, INC.
Posard Matthew L.DirectorSell$2.0M
Jun 22NAUT
Nautilus Biotechnology, Inc.
Posard Matthew L.DirectorAward$102.6K
May 7HALO
HALOZYME THERAPEUTICS, INC.
Posard Matthew L.DirectorGrant$397.9K

4 filings